Welcome to Ir.vivus.com - Investor Relations

ir.vivus.com

Description: Ir Vivus. The Investor Relations website contains information about Vivus LLC's business for stockholders, potential investors, and...

Google PR 4

Trustworthiness Good
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Good

Investor Relations | Vivus LLC

Ir.vivus.com: get to the top rated Ir Vivus pages and content popular with Mexico-based Ir.vivus.com users or check the following digest to find out more. Ir.vivus.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Ir Vivus team are just starting to conquer the social media and they have already achieved a promising result — 8 user activities so far (Twitter dominates with around 94% of all user reactions). Ir.vivus.com is hosted with Akamai Technologies, Inc. in United States. Ir Vivus traffic is not yet estimated by Alexa.

Visit ir.vivus.com

Domain info

Location:	United States
Registrant:	PERFECT PRIVACY, LLC
Hosted by:	Akamai Technologies, Inc.
Registrar:	Network Solutions, LLC
Subnetworks:	23.48.104.101, 23.48.104.111

Social Media Activities

Facebook likes: -
Twitter mentions: 7
Google pluses: -
LinkedIn mentions: 1
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Ir.vivus.com popular pages to visit

VIVUS, Inc. - FDA Advisory Committee Recommends Approval of Qnexa® FDA Advisory Committee Recommends Approval of Qnexa® MOUNTAIN VIEW, Calif., VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs A...

Investor Relations | Vivus LLC The Investor Relations website contains information about Vivus LLC's business for stockholders, potential investors, and financial analysts.

VIVUS, Inc. - Stock Information VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health.